Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00056277 · ClinicalTrials.gov registry record · Phase 3
Bipolar Disorder Study for Men and Women
A Phase 3 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 3
- Development phase
- 150
- Enrollment target
NCT00056277 is a Phase 3 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 150 participants.
The verdict
NCT00056277, a Phase 3 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 150 participants
- Enrollment target
Study Summary
A Placebo Controlled Study Evaluating Efficacy and Safety of Medication in Patients with Bipolar Disorder
Interventions
- DRUG lamotrigine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2003-02-27 |
| Est. Completion | 2005-12-14 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00056277
The ClinicalTrials.gov registry entry for NCT00056277 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which lamotrigine is the first listed.
NCT00056277 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00056277 about?
NCT00056277 is a clinical study titled "Bipolar Disorder Study for Men and Women". A Placebo Controlled Study Evaluating Efficacy and Safety of Medication in Patients with Bipolar Disorder
What is the current status of trial NCT00056277?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 150 participants. The study started on 2003-02-27. Estimated completion is 2005-12-14.
What interventions are being tested in trial NCT00056277?
The interventions under investigation include: lamotrigine (DRUG).
Who is sponsoring clinical trial NCT00056277?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.